1. Home
  2. IH vs KPTI Comparison

IH vs KPTI Comparison

Compare IH & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IH
  • KPTI
  • Stock Information
  • Founded
  • IH 1996
  • KPTI 2008
  • Country
  • IH China
  • KPTI United States
  • Employees
  • IH N/A
  • KPTI N/A
  • Industry
  • IH Other Consumer Services
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IH Real Estate
  • KPTI Health Care
  • Exchange
  • IH Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • IH 96.9M
  • KPTI 81.1M
  • IPO Year
  • IH 2020
  • KPTI 2013
  • Fundamental
  • Price
  • IH $1.85
  • KPTI $0.62
  • Analyst Decision
  • IH
  • KPTI Strong Buy
  • Analyst Count
  • IH 0
  • KPTI 4
  • Target Price
  • IH N/A
  • KPTI $5.00
  • AVG Volume (30 Days)
  • IH 21.6K
  • KPTI 768.4K
  • Earning Date
  • IH 02-27-2025
  • KPTI 02-19-2025
  • Dividend Yield
  • IH 4.54%
  • KPTI N/A
  • EPS Growth
  • IH N/A
  • KPTI N/A
  • EPS
  • IH 0.28
  • KPTI N/A
  • Revenue
  • IH $134,002,994.00
  • KPTI $148,442,000.00
  • Revenue This Year
  • IH $15.90
  • KPTI $4.47
  • Revenue Next Year
  • IH $8.64
  • KPTI $7.35
  • P/E Ratio
  • IH $6.65
  • KPTI N/A
  • Revenue Growth
  • IH N/A
  • KPTI 1.77
  • 52 Week Low
  • IH $1.47
  • KPTI $0.58
  • 52 Week High
  • IH $2.48
  • KPTI $1.70
  • Technical
  • Relative Strength Index (RSI)
  • IH 63.52
  • KPTI 43.29
  • Support Level
  • IH $1.69
  • KPTI $0.58
  • Resistance Level
  • IH $1.70
  • KPTI $0.67
  • Average True Range (ATR)
  • IH 0.08
  • KPTI 0.05
  • MACD
  • IH 0.02
  • KPTI -0.00
  • Stochastic Oscillator
  • IH 92.59
  • KPTI 31.02

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: